Cargando…
How does doxorubicin work?
A new mechanism involving cleavage of a transcription factor called CREB3L1 has been proposed to explain the anti-tumour effects of doxorubicin.
Autores principales: | Patel, Anand G, Kaufmann, Scott H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524826/ https://www.ncbi.nlm.nih.gov/pubmed/23256047 http://dx.doi.org/10.7554/eLife.00387 |
Ejemplares similares
-
Construction of a ceRNA network of regulated ferroptosis in doxorubicin-induced myocardial injury
por: Ye, Hongwei, et al.
Publicado: (2023) -
Doxorubicin blocks proliferation of cancer cells through proteolytic activation of CREB3L1
por: Denard, Bray, et al.
Publicado: (2012) -
Luteolin attenuates doxorubicin-induced cardiotoxicity by modulating the PHLPP1/AKT/Bcl-2 signalling pathway
por: Zhang, YanDong, et al.
Publicado: (2020) -
Hyperoside alleviates doxorubicin-induced myocardial cells apoptosis by inhibiting the apoptosis signal-regulating kinase 1/p38 pathway
por: Chen, Lingxia, et al.
Publicado: (2023) -
Gently does it for submicron crystals
por: Zeldin, Oliver B, et al.
Publicado: (2013)